Technical Analysis for INO - Inovio Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
C 12.00 -6.18% -0.79
INO closed down 6.18 percent on Friday, May 17, 2024, on approximately normal volume.
Earnings due: May 20
*** please verify all earnings dates ***
4 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Up

Date Alert Name Type % Chg
Wide Bands Range Expansion -6.18%
Upper Bollinger Band Touch Strength -6.18%
MACD Bullish Signal Line Cross Bullish -8.19%
Expansion Pivot Buy Setup Bullish Swing Setup -8.19%
Pocket Pivot Bullish Swing Setup -8.19%
Wide Bands Range Expansion -8.19%
Above Upper BB Strength -8.19%
Gapped Up Strength -8.19%
Up 3 Days in a Row Strength -8.19%
Upper Bollinger Band Touch Strength -8.19%

   Recent Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Inovio Pharmaceuticals, Inc. Description

Inovio Pharmaceuticals, Inc., together with its subsidiaries, engages in the discovery and development of synthetic vaccines and immune therapies focusing on cancers and infectious diseases. The company's DNA-based SynCon technology enables the design of vaccines capable of providing cross-protection against new, unmatched strains of pathogens, such as influenza. Its electroporation DNA delivery technology uses controlled electrical pulses to enhance cellular DNA vaccine uptake. The company's clinical programs include human papillomavirus/cervical cancer (therapeutic), avian influenza (preventive), prostate cancer (therapeutic), leukemia (therapeutic), hepatitis C virus, hepatitis B virus, human immunodeficiency virus, and malaria vaccines. It is also advancing preclinical research for a seasonal/pandemic influenza vaccine, as well as other products. Inovio Pharmaceuticals, Inc. has collaboration and license agreements with VGX International, Merck, and ChronTech. The company was formerly known as Inovio Biomedical Corporation and changed its name to Inovio Pharmaceuticals, Inc. in May 2010. Inovio Pharmaceuticals, Inc. was founded in 1983 and is headquartered in Blue Bell, Pennsylvania.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Cancer Infectious Diseases Prostate Cancer Clinical Research Vaccines Influenza Coronavirus Hepatitis B Leukemia Vaccination Hepatitis C Immunodeficiency Hepatitis C Virus Virus Hepatitis B Virus Malaria Virology Influenza Vaccine Papillomavirus Cervical Cancer Avian Influenza Electroporation Seasonal/Pandemic Influenza

Is INO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 14.748
52 Week Low 3.888
Average Volume 430,765
200-Day Moving Average 7.23
50-Day Moving Average 11.40
20-Day Moving Average 11.32
10-Day Moving Average 11.65
Average True Range 0.94
RSI (14) 54.55
ADX 20.45
+DI 28.74
-DI 20.47
Chandelier Exit (Long, 3 ATRs) 10.63
Chandelier Exit (Short, 3 ATRs) 12.10
Upper Bollinger Bands 12.98
Lower Bollinger Band 9.66
Percent B (%b) 0.71
BandWidth 29.30
MACD Line 0.33
MACD Signal Line 0.20
MACD Histogram 0.1222
Fundamentals Value
Market Cap 272.99 Million
Num Shares 22.7 Million
EPS -7.56
Price-to-Earnings (P/E) Ratio -1.59
Price-to-Sales 179.54
Price-to-Book 1.11
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 13.22
Resistance 3 (R3) 13.29 12.95 13.01
Resistance 2 (R2) 12.95 12.64 12.92 12.94
Resistance 1 (R1) 12.48 12.45 12.31 12.41 12.88
Pivot Point 12.14 12.14 12.06 12.11 12.14
Support 1 (S1) 11.67 11.83 11.50 11.60 11.12
Support 2 (S2) 11.33 11.64 11.30 11.06
Support 3 (S3) 10.86 11.33 10.99
Support 4 (S4) 10.79